AstraZeneca approaches US rival Gilead Sciences to discuss merger By Daily Mail City & Finance Reporter Published: 21:52 BST, 7 June 2020 | Updated: 21:52 BST, 7 June 2020 In what would be the largest healthcare deal on record, AstraZeneca has approached its US rival Gilead Sciences to discuss a merger. AstraZeneca, which is listed … Read more
Five years, minimum. That’s how long it usually takes to develop a vaccine. Yet of the 78 being worked on for Covid-19, five are already in trials — and not just in labs; most are being tested on humans. Last month, a microbiology researcher at the University of Oxford became the first UK volunteer to … Read more
Five years, minimum. That’s how long it usually takes to develop a vaccine. Yet of the 78 being worked on for Covid-19, five are already in trials — and not just in labs; most are being tested on humans. Last month, a microbiology researcher at the University of Oxford became the first UK volunteer to … Read more
Abbott Laboratories said on Friday it won the federal government’s marketing approval for a diagnostic test for the coronavirus that can deliver results to patients within minutes. The medical device company based in Lake Bluff, Illinois, said that the test can be used in physicians’ offices and urgent care clinics as well as hospitals. The … Read more